Patient & Survivor Care
From the Journals
Polygenic Risk Scores Improve Breast Cancer Screening
Researchers examine how well polygenic risk scores predict a person's risk for any breast cancer as well as invasive, in situ, and bilateral at...
Commentary
A Banned Chemical That Is Still Causing Cancer
This carcinogen ‘is still around: in our soil, in our food, and in our blood.’
From the Journals
Active Surveillance for Cancer Doesn’t Increase Malpractice Risk
Researchers identify malpractice trends involving active surveillance related to thyroid, prostate, kidney, and...
Conference Coverage
It Takes a Village: Treating Patients for NSCLC Brain Metastases
Multidisciplinary teams need to weigh options that may include immunotherapy, chemotherapy, targeted agents, and local therapy.
Feature
Women’s Cancers: Clinicians Research, Advise on Sexual Dysfunction
New research highlights the importance of discussing risks of sexual dysfunction in patients with women’s cancers.
Conference Coverage
Debate: Does ctDNA Have Role in Monitoring Tx Efficacy in Lung Cancer?
Experts debate whether liquid biopsy can provide useful clinical information beyond prognostication in the postoperative setting.
Commentary
Diarrhea in Cancer Therapies — Part 1: Chemotherapeutics
Oncologist and gastroenterologist discuss treatment methods and guidelines for patients experiencing diarrhea from chemotherapy.
Conference Coverage
Savolitinib Active Against MET Ex14 Mutated NSCLC
Savolitinib was associated with similar progression-free survival as both first- and second-line therapy for patients with locally advanced or...
Latest News
New Guidance for the Treatment of Metastatic Breast Cancer
The ABC International Consensus Guidelines discuss situations in clinical practice that don’t have strong data suggesting the best path to take....
From the Journals
Few Childhood Cancer Survivors Get Recommended Screenings
‘As many as four out of five of these survivors will develop a serious or life-threatening late effect of their cancer therapy by age 45,’ the...
Conference Coverage
Minimally Invasive Cytoreductive Approach Comparable to Open Surgery for Ovarian Cancer
There were no differences in survival for patients with complete gross resections who underwent interval debulking via laparoscopy/robotics or...